Commercial The Rare Journey Needs a Special Pharmacy Partner Drug ChannelsToday's guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.CommercialRare DiseaseRead full story pharminent March 27, 2026 (Last updated: March 30, 2026) Drug Channels Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare. CommercialRare DiseaseRead full story Post navigation Previous: Merck’s deal for Terns sparks debate over a possible biotech bidding warNext: Novartis targets Xolair successor in buyout of startup Excellergy Related Stories Commercial Novo’s CEO champions “record-breaking start” for Wegovy pill in US market pharminent May 8, 2026 Commercial Novo hikes guidance on Wegovy pill’s fast sales start pharminent May 6, 2026 Commercial Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales pharminent May 6, 2026
